Skip to main content

Fulminant Hepatic Failure clinical trials at UCSF

1 research study open to eligible people

Fulminant hepatic failure is a sudden and severe liver injury that can be life-threatening. A clinical trial at UCSF is looking for children with this condition to take part in a study called TRIUMPH. The study is testing the effectiveness of immunosuppressive therapy with three different treatment plans.

Showing trials for
  • TReatment for ImmUne Mediated PathopHysiology

    open to eligible people ages 1-18

    TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.

    San Francisco, California and other locations

Last updated: